# A New Center for Rare Diseases Established Aiming to streamline gene therapy processes. - **Source:** [NYT > Science](https://brifing.si/source/794f9fbd-c10f-44d6-932d-9039af67922c) - **Published:** 2026-07-21 - **Topic:** [Business](https://brifing.si/c/business) - **Original article:** - **On Brifing:** https://brifing.si/s/57c843de-7b8f-4bdb-b83d-88b1e730dabb ## A New Initiative Focused on Rare Diseases Rare diseases are often overlooked by pharmaceutical companies. A new nonprofit aims to streamline gene therapy processes for these conditions, potentially making treatments more routine. ## The Potential of Gene Therapy Gene therapy holds promise for rare diseases, but the processes are complex and costly. The new center aims to overcome these barriers, making treatments more accessible. ## Pharmaceutical Companies' Disinterest Due to the small market size, pharmaceutical companies often ignore rare diseases. This makes it difficult for patients to access treatment. The new initiative aims to fill this gap. ## Standardizing Treatment Processes The new center plans to standardize gene therapy processes, making treatments faster and more effective. This could be a significant advantage for patients. ## Patient-Centric Approach The organization is shaping treatment processes with patients' needs at the forefront. This approach is seen as a crucial step in combating rare diseases. ## Future Impacts This initiative could be a turning point in the treatment of rare diseases. Streamlining gene therapy processes may enable more patients to access treatment. ## Sources covering this story - https://www.nytimes.com/2026/07/21/health/gene-therapy-rare-diseases-epilepsy.html — --- _Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._